Overall rank by patents
#14,193
Across all tracked assignees
USPTO PatentsView assignee record - 21 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Orpyx holds 21 US patents across 20 technology areas, rank #14,193 of 50,000 tracked assignees.
Orpyx Medical Technologies Inc. has been granted 21 US utility patents between 2015 and 2025, placing Orpyx Medical Technologies Inc. at rank #14,193 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Orpyx Medical Technologies Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Orpyx sits between Open Water Internet, Inc. (21 patents, rank #14,189) and PDSI (21 patents, rank #14,197) - the closest US assignees by grant volume. The composite Innovation Score of 57.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 4 in the 2015–2019 window, a +325% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Orpyx Medical Technologies Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orpyx Medical Technologies Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Open Water Internet, Inc.
21 patents
OpenPeak LLC
21 patents
OpenX Technologies, Inc.
21 patents
Operr Technologies, Inc
21 patents
OrthoAccel Technologies, Inc.
21 patents
Owlstone Medical Limited
21 patents
Oz-Post International, LLC
21 patents
PDSI
21 patents
Orpyx Medical Technologies Inc.
21 patents
What this shows Orpyx holds 21 patents at rank #14,193, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #14,193 in granted patent volume.
Other assignees with the most granted patents in Orpyx's primary technology class.
Orpyx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 4.8% |
| 2017 | 1 | 4.8% |
| 2018 | 2 | 9.5% |
| 2021 | 2 | 9.5% |
| 2022 | 3 | 14.3% |
| 2023 | 5 | 23.8% |
| 2024 | 2 | 9.5% |
| 2025 | 5 | 23.8% |
Top 15 of 20 technology areas
Overall rank by patents
#14,193
Across all tracked assignees
57.3 out of 100
How to use this portfolio
Orpyx's 21 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.